生物反馈技术对抑郁发作亚临床状态的干预研究

发布时间：2018-03-21 16:49

本文选题：抑郁发作亚临床状态　切入点：生物反馈　出处：《成都中医药大学》2012年硕士论文　论文类型：学位论文

【摘要】：目的：采用随机单盲的设计方法,系统观察抑郁发作亚临床状态生物反馈治疗组和空白对照组患者3周之后的转归,探索生物反馈技术对抑郁发作亚临床状态的干预效果,以寻求一种可以影响抑郁发作亚临床状态向抑郁发作转归的治疗方式,为抑郁发作亚临床状态的治疗提供一种简便有效且安全性高,副作用小的诊疗方式。方法：将符合课题纳入标准的抑郁发作亚临床状态患者随机分为生物反馈治疗组和空白对照组,生物反馈治疗组采用脑电生物反馈治疗仪干预3周,每周治疗两次,每周评定一次；空白对照组不采用任何方法干预,观察3周,每周评定一次。连续观察3周后分析两组患者的汉密尔顿抑郁量表(HAMD)、抑郁自评量表(SDS)、流调用抑郁自评量表(CES-D)和生活满意度评分,并以HAMD的减分率作为总体疗效标准评价生物反馈治疗的疗效。结果：生物反馈治疗组与空白对照组在对抑郁发作亚临床状态的干预方面有显著差异,以]HAMD的减分率作为总体疗效标准,生物反馈治疗组疗效优于空白对照组,差异具有统计学意义(P0.0001)。而在考虑病情程度的情况下,生物反馈治疗组对HAMD评分在轻度和中度的均有效,且轻中度之间疗效差异无统计学意义。SDS和CES-D的评分较治疗前也明显下降,生活满意度评分升高,两组间差异具有统计学意义(P0.0001)。结论：生物反馈技术干预抑郁发作亚临床状态,能降低受试者SDS、HAMD、 CES-D的评分,提高其生活满意度。生物反馈技术能有效改善患者的抑郁发作亚临床状态的症状,降低抑郁发作亚临床状态向抑郁发作不良转归的趋势。抑郁发作亚临床状态是能够在一定程度上被控制或终止的,值得引起重视。生物反馈技术在抑郁发作亚临床状态的临床诊疗方面效果肯定,值得深入研究。
[Abstract]:Objective: to investigate the effect of biofeedback on the subclinical state of depression after 3 weeks in patients in the subclinical state of depression treatment group and blank control group by using a randomized, single-blind design, and to explore the effect of biofeedback on the subclinical state of depression. In order to find a treatment that can affect the subclinical state of depression to depressive attack, and provide a simple, effective, safe and less side effect way for the treatment of depression subclinical state. Methods: patients with subclinical state of depression were randomly divided into biofeedback treatment group and blank control group. The biofeedback treatment group was treated with EEG biofeedback therapy for 3 weeks, twice a week. The blank control group did not take any intervention and observed for 3 weeks. Hamilton Depression scale (Hamd), self rating Depression scale (SDS), self rating Depression scale (SDS), flow call Depression scale (SDS) and Life satisfaction scale (life satisfaction) were analyzed after 3 weeks of continuous observation. The efficacy of biofeedback therapy was evaluated by using the score reduction rate of HAMD as the overall therapeutic standard. Results: there was significant difference between the biofeedback treatment group and the blank control group in the intervention of the subclinical state of depression. The efficacy of biofeedback treatment group was better than that of the blank control group. The difference was statistically significant (P 0.0001). However, the biofeedback treatment group was effective in mild and moderate HAMD scores, and the scores of CES-D and CES-D were significantly lower than those before treatment, and there was no significant difference between mild and moderate therapeutic effects. The score of life satisfaction increased, and the difference between the two groups was statistically significant (P 0.0001). Conclusion: biofeedback intervention can decrease the scores of SDSHAMDand CES-D and improve their life satisfaction. Biofeedback technique can effectively improve the symptoms of depression in patients with subclinical state. Reduce the tendency of depression subclinical state to depressive attack adverse outcome. Depression subclinical state can be controlled or terminated to some extent. The effect of biofeedback technique on the diagnosis and treatment of subclinical state of depression is positive and worthy of further study.
【学位授予单位】：成都中医药大学
【学位级别】：硕士
【学位授予年份】：2012
【分类号】：R749.4

【参考文献】